This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
BioInvent International AB
Drug Names(s): BI-505
Description: BI-505 is a fully human antibody derived from BioInvent's proprietary n-CoDeR library. The antibody binds to the adhesion protein ICAM-1 (CD54) whose levels are elevated in tumor cells. In addition to inducing apoptosis the antibody also stimulates the immune system to eliminate tumor cells through antibody dependent cell-mediated cytotoxicity.
Additional information available to subscribers only: